Cynvec LLC
Immunotherapeutic in the Cancer space focusing at a IND approval for Ovarian Cancer. Currently raising funds to support this effort.
- Presenter: Steven Blumenthal, CBO
- Commercial Catalysts: Fred Banti and Phil Crowley
- Defined Milestone: Strategically plan fund raise to support IND needs
- Targeted Completion: 5 months